Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMPACT OF 18F-DCFPyL PET/CT ON INITIAL AND SUBSEQUENT TREATMENT STRATEGIES OF PATIENTS WITH PROSTATE CANCER (PROSPYL)

NCT04390880 is registered in ClinicalTrials.gov with VA Greater Los Angeles Healthcare System as lead sponsor.

NCT NCT04390880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04390880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMPACT OF 18F-DCFPyL PET/CT ON INITIAL AND SUBSEQUENT TREATMENT STRATEGIES OF PATIENTS WITH PROSTATE CANCER (PROSPYL)
Lead sponsor
VA Greater Los Angeles Healthcare System
Phase
Phase 2
Overall status
Completed
Start date
April 7, 2020
Completion date
August 31, 2021
Enrollment
239 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer